Mersana Therapeutics To Be Acquired By Day One Biopharmaceuticals For Up To $285 Mln
(RTTNews) - Mersana Therapeutics, Inc. (MRSN), a biopharmaceutical company, Thursday, announced that it has entered a definitive agreement to be acquired by Day One Biopharmaceuticals through a...
Nasdaq News: Markets·3h ago